These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36370997)

  • 1. A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect.
    Bjørnstad R; Reiten IN; Knudsen KS; Schjøtt J; Herfindal L
    Int J Pharm; 2022 Dec; 629():122379. PubMed ID: 36370997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines.
    Duarte JA; Gomes ER; De Barros ALB; Leite EA
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
    Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
    Sarfraz M; Afzal A; Raza SM; Bashir S; Madni A; Khan MW; Ma X; Xiang G
    Oncotarget; 2017 Jul; 8(29):47136-47153. PubMed ID: 28525367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination.
    Chen B; Zhang JP
    Phytomedicine; 2022 Jul; 101():154130. PubMed ID: 35526324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
    Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
    Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herceptin-conjugated liposomes co-loaded with doxorubicin and simvastatin in targeted prostate cancer therapy.
    Li N; Xie X; Hu Y; He H; Fu X; Fang T; Li C
    Am J Transl Res; 2019; 11(3):1255-1269. PubMed ID: 30972160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation.
    Yu JL; Jin Y; Cao XY; Gu HH
    Hum Cell; 2020 Jan; 33(1):47-56. PubMed ID: 31643023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin.
    Meng X; Zhang H; Chen L; Wang M; Zhang K; Liu X; Deng Y; Song Y
    AAPS PharmSciTech; 2023 Feb; 24(2):64. PubMed ID: 36759405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
    Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
    Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
    Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
    Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes.
    Bartkowiak A; Nazaruk E; Gajda E; Godlewska M; Gaweł D; Jabłonowska E; Bilewicz R
    ACS Biomater Sci Eng; 2022 Oct; 8(10):4354-4364. PubMed ID: 36173110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
    Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
    J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-Oncology's Modern Approaches to Prevent Doxorubicin-Induced Cardiotoxicity: A Systematic Review.
    Palvia AR; Damera AR; Nandi AR; Magar S; Patidar S; Kasarla S; Ghantasala V; Shah MK; Goyal M
    Cureus; 2024 Aug; 16(8):e66215. PubMed ID: 39238705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy.
    Gabizon A; Ohana P; Amitay Y; Gorin J; Tzemach D; Mak L; Shmeeda H
    Cancer Drug Resist; 2021; 4(2):463-484. PubMed ID: 35582027
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.